Portal Biotech Raises $35 Million Series A | Leveraging AI to Deliver the World’s First Full-Length Single-Molecule Protein Sequencer
Breakthrough proteomics platform technology unlocks full-length protein sequencing and characterisation, accelerating drug development and diagnostics
